Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/21925
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.contributor.author | Yıldız, Ayşegül | - |
dc.contributor.author | Güzel, Orkide | - |
dc.contributor.author | Kılıç, Erdinç | - |
dc.contributor.author | Schaebitz, Wolf Ruediger | - |
dc.contributor.author | Kılıç, Ertuğrul | - |
dc.date.accessioned | 2021-09-14T07:55:24Z | - |
dc.date.available | 2021-09-14T07:55:24Z | - |
dc.date.issued | 2006-05-31 | - |
dc.identifier.citation | Yulug, B. vd. (2006). ''Risperidone attenuates brain damage after focal cerebral ischemia in vivo''. Brain Research Bulletin, 69(6), 656-659. | en_US |
dc.identifier.issn | 0361-9230 | - |
dc.identifier.issn | 1873-2747 | - |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0361923006001110 | - |
dc.identifier.uri | https://doi.org/10.1016/j.brainresbull.2006.03.017 | - |
dc.identifier.uri | http://hdl.handle.net/11452/21925 | - |
dc.description.abstract | Since their introduction, atypical neuroleptic agents have been discovered to have some beneficial effects beyond their effectiveness as neuroleptic drugs. Among these initially unexpected effects are their potential effects as mood stabilizers in bipolar disorder and their efficacy in improving long-term outcome in schizophrenia. These effects recently raised the question whether these drugs may also have some neuroprotective effect in the brain. To examine this matter, in this study we evaluated the neuroprotective effect of risperidone after permanent focal cerebral ischemia. Anaesthetized male C57BL/6j mice were submitted to permanent thread occlusion of the middle cerebral artery (MCA). Risperidone (0.1, 1 or 10 mg/kg) or vehicle was applied intraperitoneally just after permanent ischemia. Twenty-four hours after permanent ischemia, brain injury was evaluated by triphenyltetrazolium, chloride staining (TTC). Risperidone (0.1, 1 and 10 mg/kg) showed significant neuroprotection after permanent focal cerebral ischemia. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Pergamon-Elsevier Science | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Stroke | en_US |
dc.subject | Risperidone | en_US |
dc.subject | Neuroprotection | en_US |
dc.subject | Cerebral ischemia | en_US |
dc.subject | Acid | en_US |
dc.subject | Protein | en_US |
dc.subject | Schizophrenia | en_US |
dc.subject | Stroke | en_US |
dc.subject | Rat | en_US |
dc.subject | Messenger-rna | en_US |
dc.subject | Striatal dopamine | en_US |
dc.subject | Early intervention | en_US |
dc.subject | Incomplete ischemia | en_US |
dc.subject | Long-term morbidity | en_US |
dc.title | Risperidone attenuates brain damage after focal cerebral ischemia in vivo | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000238180400010 | tr_TR |
dc.identifier.scopus | 2-s2.0-33646571947 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı. | tr_TR |
dc.identifier.startpage | 656 | tr_TR |
dc.identifier.endpage | 659 | tr_TR |
dc.identifier.volume | 69 | tr_TR |
dc.identifier.issue | 6 | tr_TR |
dc.relation.journal | Brain Research Bulletin | en_US |
dc.contributor.buuauthor | Yulug, Burak | - |
dc.relation.collaboration | Yurt içi | tr_TR |
dc.relation.collaboration | Yurt dışı | tr_TR |
dc.identifier.pubmed | 16716834 | tr_TR |
dc.subject.wos | Neurosciences | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.subject.scopus | Common Carotid Artery; Fluoro Jade; Gerbillinae | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.